134 related articles for article (PubMed ID: 37777964)
1. CPSF6 regulates alternative polyadenylation and proliferation of cancer cells through phase separation.
Liu S; Wu R; Chen L; Deng K; Ou X; Lu X; Li M; Liu C; Chen S; Fu Y; Xu A
Cell Rep; 2023 Oct; 42(10):113197. PubMed ID: 37777964
[TBL] [Abstract][Full Text] [Related]
2. Disruption of PABPN1 phase separation by SNRPD2 drives colorectal cancer cell proliferation and migration through promoting alternative polyadenylation of CTNNBIP1.
Hu Z; Li M; Chen Y; Chen L; Han Y; Chen C; Lu X; You N; Lou Y; Huang Y; Huo Z; Liu C; Liang C; Liu S; Deng K; Chen L; Chen S; Wan G; Wu X; Fu Y; Xu A
Sci China Life Sci; 2024 Jun; 67(6):1212-1225. PubMed ID: 38811444
[TBL] [Abstract][Full Text] [Related]
3. Differential role for phosphorylation in alternative polyadenylation function versus nuclear import of SR-like protein CPSF6.
Jang S; Cook NJ; Pye VE; Bedwell GJ; Dudek AM; Singh PK; Cherepanov P; Engelman AN
Nucleic Acids Res; 2019 May; 47(9):4663-4683. PubMed ID: 30916345
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of CPSF6 leads to global mRNA 3' UTR shortening and enhanced antiviral immune responses.
Ge Y; Huang J; Chen R; Fu Y; Ling T; Ou X; Rong X; Cheng Y; Lin Y; Zhou F; Lu C; Yuan S; Xu A
PLoS Pathog; 2024 Feb; 20(2):e1012061. PubMed ID: 38416782
[TBL] [Abstract][Full Text] [Related]
5. CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression.
Tan S; Zhang M; Shi X; Ding K; Zhao Q; Guo Q; Wang H; Wu Z; Kang Y; Zhu T; Sun J; Zhao X
J Exp Clin Cancer Res; 2021 Mar; 40(1):85. PubMed ID: 33648552
[TBL] [Abstract][Full Text] [Related]
6. Mutation in cpsf6/CFIm68 (Cleavage and Polyadenylation Specificity Factor Subunit 6) causes short 3'UTRs and disturbs gene expression in developing embryos, as revealed by an analysis of primordial germ cell migration using the medaka mutant naruto.
Sasado T; Kondoh H; Furutani-Seiki M; Naruse K
PLoS One; 2017; 12(3):e0172467. PubMed ID: 28253363
[TBL] [Abstract][Full Text] [Related]
7. The HIV-1 capsid-binding host factor CPSF6 is post-transcriptionally regulated by the cellular microRNA miR-125b.
Chaudhuri E; Dash S; Balasubramaniam M; Padron A; Holland J; Sowd GA; Villalta F; Engelman AN; Pandhare J; Dash C
J Biol Chem; 2020 Apr; 295(15):5081-5094. PubMed ID: 32152226
[TBL] [Abstract][Full Text] [Related]
8. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
[TBL] [Abstract][Full Text] [Related]
9. Requirement for cleavage factor II
Turner RE; Henneken LM; Liem-Weits M; Harrison PF; Swaminathan A; Vary R; Nikolic I; Simpson KJ; Powell DR; Beilharz TH; Dichtl B
RNA; 2020 Aug; 26(8):969-981. PubMed ID: 32295865
[TBL] [Abstract][Full Text] [Related]
10. Cleavage factor Im is a key regulator of 3' UTR length.
Gruber AR; Martin G; Keller W; Zavolan M
RNA Biol; 2012 Dec; 9(12):1405-12. PubMed ID: 23187700
[TBL] [Abstract][Full Text] [Related]
11. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
[TBL] [Abstract][Full Text] [Related]
12. Cleavage factor Im (CFIm) as a regulator of alternative polyadenylation.
Hardy JG; Norbury CJ
Biochem Soc Trans; 2016 Aug; 44(4):1051-7. PubMed ID: 27528751
[TBL] [Abstract][Full Text] [Related]
13. Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing.
Fu Y; Sun Y; Li Y; Li J; Rao X; Chen C; Xu A
Genome Res; 2011 May; 21(5):741-7. PubMed ID: 21474764
[TBL] [Abstract][Full Text] [Related]
14. Suppression of CPSF6 Enhances Apoptosis Through Alternative Polyadenylation-Mediated Shortening of the
Shi X; Ding K; Zhao Q; Li P; Kang Y; Tan S; Sun J
Front Genet; 2021; 12():707644. PubMed ID: 34594359
[TBL] [Abstract][Full Text] [Related]
15. Alternative polyadenylation alters protein dosage by switching between intronic and 3'UTR sites.
de Prisco N; Ford C; Elrod ND; Lee W; Tang LC; Huang KL; Lin A; Ji P; Jonnakuti VS; Boyle L; Cabaj M; Botta S; Õunap K; Reinson K; Wojcik MH; Rosenfeld JA; Bi W; Tveten K; Prescott T; Gerstner T; Schroeder A; Fong CT; George-Abraham JK; Buchanan CA; Hanson-Khan A; Bernstein JA; Nella AA; Chung WK; Brandt V; Jovanovic M; Targoff KL; Yalamanchili HK; Wagner EJ; Gennarino VA
Sci Adv; 2023 Feb; 9(7):eade4814. PubMed ID: 36800428
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression.
Lianoglou S; Garg V; Yang JL; Leslie CS; Mayr C
Genes Dev; 2013 Nov; 27(21):2380-96. PubMed ID: 24145798
[TBL] [Abstract][Full Text] [Related]
17. CFIm-mediated alternative polyadenylation safeguards the development of mammalian pre-implantation embryos.
Li N; Cai Y; Zou M; Zhou J; Zhang L; Zhou L; Xiang W; Cui Y; Li H
Stem Cell Reports; 2023 Jan; 18(1):81-96. PubMed ID: 36563685
[TBL] [Abstract][Full Text] [Related]
18. Cleavage and Polyadenylation Specificity Factor 6 Is Required for Efficient HIV-1 Latency Reversal.
Zheng Y; Schubert HL; Singh PK; Martins LJ; Engelman AN; D'Orso I; Hill CP; Planelles V
mBio; 2021 Jun; 12(3):e0109821. PubMed ID: 34154414
[TBL] [Abstract][Full Text] [Related]
19. The roles of CPSF6 in proliferation, apoptosis and tumorigenicity of lung adenocarcinoma.
Zu Y; Wang D; Ping W; Sun W
Aging (Albany NY); 2022 Nov; 14(22):9300-9316. PubMed ID: 36446361
[TBL] [Abstract][Full Text] [Related]
20. Molecular Regulation of Alternative Polyadenylation (APA) within the Drosophila Nervous System.
Vallejos Baier R; Picao-Osorio J; Alonso CR
J Mol Biol; 2017 Oct; 429(21):3290-3300. PubMed ID: 28366829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
